Stewart A K, Kurschat C E, Vaughan-Jones R D, Shmukler B E, Alper S L
Department of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
J Physiol. 2007 Oct 1;584(Pt 1):59-73. doi: 10.1113/jphysiol.2007.136119. Epub 2007 Aug 9.
The widely expressed anion exchanger polypeptide AE2/SLC4A2 is acutely inhibited by acidic intracellular (pH(i)), by acidic extracellular pH (pH(o)), and by the calmodulin inhibitor, calmidazolium, whereas it is acutely activated by NH(4)(+). The homologous erythroid/kidney AE1/SLC4A1 polypeptide is insensitive to these regulators. Each of these AE2 regulatory responses requires the presence of AE2's C-terminal transmembrane domain (TMD). We have now measured (36)Cl(-) efflux from Xenopus oocytes expressing bi- or tripartite AE2-AE1 chimeras to define TMD subregions in which AE2-specific sequences contribute to acute regulation. The chimeric AE polypeptides were all functional at pH(o) 7.4, with the sole exception of AE2((1-920))/AE1((613-811))/AE2((1120-1237)). Reciprocal exchanges of the large third extracellular loops were without effect. AE2 regulation by pH(i), pH(o) and NH(4)(+) was retained after substitution of C-terminal AE2 amino acids 1120-1237 (including the putative second re-entrant loop, two TM spans and the cytoplasmic tail) with the corresponding AE1 sequence. In contrast, the presence of this AE2 C-terminal sequence was both necessary and sufficient for inhibition by calmidazolium. All other tested TMD substitutions abolished AE2 pH(i) sensitivity, abolished or severely attenuated sensitivity to pH(o) and removed sensitivity to NH(4)(+). Loss of AE2 pH(i) sensitivity was not rescued by co-expression of a complementary AE2 sequence within separate full-length chimeras or AE2 subdomains. Thus, normal regulation of AE2 by pH and other ligands requires AE2-specific sequence from most regions of the AE2 TMD, with the exceptions of the third extracellular loop and a short C-terminal sequence. We conclude that the individual TMD amino acid residues previously identified as influencing acute regulation of AE2 exert that influence within a regulatory structure requiring essential contributions from multiple regions of the AE2 TMD.
广泛表达的阴离子交换多肽AE2/SLC4A2受到细胞内酸性pH值(pH(i))、细胞外酸性pH值(pH(o))以及钙调蛋白抑制剂氯咪巴唑的急性抑制,而受到NH(4)(+)的急性激活。同源的红细胞/肾脏AE1/SLC4A1多肽对这些调节剂不敏感。AE2的每种调节反应都需要AE2的C末端跨膜结构域(TMD)的存在。我们现在已经测量了表达双或三方AE2-AE1嵌合体的非洲爪蟾卵母细胞的(36)Cl(-)流出,以确定AE2特异性序列对急性调节有贡献的TMD亚区域。嵌合AE多肽在pH(o) 7.4时均具有功能,但AE2((1-920))/AE1((613-811))/AE2((1120-1237))除外。大的第三个细胞外环的相互交换没有效果。在用相应的AE1序列替换C末端AE2氨基酸1120-1237(包括假定的第二个折返环、两个跨膜片段和细胞质尾巴)后,AE2对pH(i)、pH(o)和NH(4)(+)的调节得以保留。相反,该AE2 C末端序列的存在对于氯咪巴唑的抑制作用既是必要的也是充分的。所有其他测试的TMD替换都消除了AE2对pH(i)的敏感性,消除或严重减弱了对pH(o)的敏感性,并消除了对NH(4)(+)的敏感性。通过在单独的全长嵌合体或AE2亚结构域内共表达互补的AE2序列,无法挽救AE2对pH(i)敏感性的丧失。因此,AE2受pH和其他配体的正常调节需要AE2 TMD大多数区域的AE2特异性序列,但第三个细胞外环和短的C末端序列除外。我们得出结论,先前确定的影响AE2急性调节的单个TMD氨基酸残基是在一个需要AE2 TMD多个区域做出重要贡献的调节结构内发挥这种影响的。